Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Nov 30.

Published in final edited form as: Diabetes Care. 2007 Oct 24;31(2):289–294. doi: 10.2337/dc07-1338

Changes in inflammatory markers and mediators. A: Adiponectin increased significantly in the salsalate-treated group compared with the placebo group. B: CRP and FFA were lower after salsalate (upper panel) but unchanged after placebo (lower panel) by within-group analysis (*P < 0.05). , baseline; ■, after therapy.

Inline graphic — Changes in inflammatory markers and mediators. A: Adiponectin increased significantly in the salsalate-treated group compared with the placebo group. B: CRP and FFA were lower after salsalate (upper panel) but unchanged after placebo (lower panel) by within-group analysis (*P < 0.05). , baseline; ■, after therapy.